Healthcare & Life Sciences
Lutris Pharma
Lutris Pharma is a Healthcare & Life Sciences startup based in Spain, most recent round Series A, 1 tracked investor.
activeseries-a
series-a
Stage
1
Investors
About Lutris Pharma
Based in Spain, Lutris Pharma is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Lutris Pharma is a clinical-stage biopharmaceutical company developing a novel topical B-RAF inhibitor gel, LUT014, to treat skin toxicities such as acneiform rash caused by cancer therapies, aiming to improve treatment tolerability and patient quality of life.
Explore Lutris Pharma's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.